Search Results

0 results for 'Boehringer Ingelheim'

You can use to get even better search results Boehringer Ingelheim
October 28, 2024 | New York Law Journal

King & Spalding Adds Veteran Antitrust Litigator From White & Case in New York

Ross Elfand spent the last 18 years at White & Case, where he worked his way up from associate to partner.
3 minute read
October 09, 2024 | Law.com

GlaxoSmithKline Settles Most Zantac Lawsuits for $2.2B

The settlement, announced on Wednesday, resolves 93% of all Zantac cases in state courts against GlaxoSmithKline.
4 minute read
September 19, 2024 | Law.com

Another Mistrial in Zantac: Fourth Illinois Jury Fails to Award Damages

On Wednesday, a jury in Cook County Circuit Court in Illinois ended in a mistrial in a case against Zantac manufacturer Boehringer Ingelheim, the second in the past two months.
6 minute read
September 04, 2024 | Law.com

Critical Mass With Law.com's Amanda Bronstad: Delaware's Highest Court Takes Up Zantac Expert Appeal, Will Convicted Tom Girardi Go to Prison?

The Delaware Supreme Court has agreed to take up an appeal of a May 31 ruling that allowed 10 plaintiffs' experts into thousands of Zantac lawsuits.
7 minute read
September 04, 2024 | Connecticut Law Tribune

Lawsuit Linking Zantac to Cancer Diagnoses Survives Fight Over Jurisdiction

Waterbury Superior Court Judge W. Glen Pierson ruled that defendants, having registered to do business in Connecticut, consented to the jurisdiction of the state's courts.
4 minute read
July 29, 2024 | Connecticut Law Tribune

Hundreds of Plaintiffs Deploy Litigation Strategy in Zantac Suits

"Juries can be fickle, and if you have to try nine cases nine times, you may get nine different results," Peter Bowman, a personal injury lawyer for BBB Attorneys, said.
3 minute read
July 17, 2024 | Law.com

Critical Mass With Law.com's Amanda Bronstad: Tom Girardi's Lawyers Want Criminal Trial Moved to October, Judge Asks: Should Roundup Settlement Program Continue?

Federal public defenders for Tom Girardi have asked to delay next month's criminal trial, alleging that prosecutors "affirmatively misled" them about the scope of the case
7 minute read
July 12, 2024 | Connecticut Law Tribune

Boehringer Ingelheim Pharmaceuticals Loses Challenge to Inflation Reduction Act

"We are disappointed by this ruling and what it means for biopharmaceutical innovation," the company said. "Boehringer Ingelheim shares the goal of ensuring our medicines are affordable and available to people who need them. However, we remain concerned about the detrimental and limiting effects the IRA and its 'negotiation' program will have on the future of innovation for the patients we serve."
3 minute read

Resources

  • Yearly Roundup: Strategic Insights for Law Firm Decision Making

    Brought to you by CARET Legal

    Download Now

  • Lex Machina Contracts: Commercial Litigation Report 2024

    Brought to you by LexisNexis®

    Download Now

  • White Collar Investigation Practice: Global Expertise in Complex Investigations

    Brought to you by HaystackID

    Download Now

  • Criminal Division's Evaluation of Corporate Compliance Programs: September 2024 Updates Review

    Brought to you by NAVEX Global

    Download Now